1-3 of 3
Albert Woelfler, MD
Close
Sort by
Journal Articles

Impact of TP53 Mutated Subclones in Acute Myeloid Leukemia

Gabriel Pabst, Katharina Prochazka, MD, Gudrun Pregartner, Frank G. Rücker, MD, Ellen Heitzer, PhD, Albert Woelfler, MD, Armin Zebisch, MD, Andrea Berghold, PhD, Konstanze Döhner, MD, Heinz Sill, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1483.
https://doi.org/10.1182/blood-2018-99-110667
Published: 2018
Journal Articles

Survival in Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis - Correlation of Clinical Phenotype with Histomorphological Diagnosis

Georg Jeryczynski, MD, Albert Woelfler, MD, Bettina Gisslinger, Martin Schalling, Sonja Burgstaller, MD, Veronika Buxhofer-Ausch, Maria Theresa Krauth, MD, Klaus Geissler, MD, Ernst Schlögl, MD, Thamer Sliwa, MD, Ana-Iris Schiefer, MD, Leonhard Muellauer, MD, Ingrid Simonitsch-Klupp, MD, Christine Beham-Schmid, MD, Jürgen Thiele, MDPhD, Heinz Gisslinger
Journal: Blood
Blood (2016) 128 (22): 1932.
https://doi.org/10.1182/blood.V128.22.1932.1932
Published: 2016
Journal Articles

Base Excision Repair Glycosylase Activity Is Impaired in a Subgroup of Acute Myeloid Leukemia Resulting in Increased Levels of Oxidative Base Lesions

Werner Olipitz, MD, Karin Lind, Nicole Monsberger, PhD, Anna Katschnig, MSc, Aswin Mangerich, PhD, Sybille Hofer, MSc, Eduard Schulz, MD, Franz Quehenberger, PhD, Dietmar Schlembach, MD, Christoph Robier, MD, Albert Woelfler, MD, Armin Zebisch, MD, Heinz Sill, MD
Journal: Blood
Blood (2014) 124 (21): 860.
https://doi.org/10.1182/blood.V124.21.860.860
Published: 2014